Viola Ventures — 2024 Investments
6 investments dated 2024 · listed companies and verified rows first · show all
PayZen provides AI-powered, interest-free patient financing that lets patients pay medical bills over time through personalized payment plans, with pre-built EHR integrations and automated servicing for providers.
AI & Machine LearningDigital HealthFintechHealthtechSan Francisco, US
Tobias Mezger(Founder)inIsaac Cohen(Executive Officer, Director)Ariel Rosenthal(Founder)inItzik Cohen(Founder)inAntonio Martino(Executive Officer)in
BoardLee Shapiro(Director)in
Board seatOmry David· per SEC Form D
Co-investors7wire VenturesSignalFireCorewell Health VenturesHaymaker VenturesLink VenturesLorimer Ventures+4 more
CTERA provides a data platform that embeds governance, protection, and compliance capabilities to help security teams reduce risk and maintain control across distributed cloud, hybrid, and on-premises environments.
AI & Machine LearningCloud ComputingCybersecurityData & InfrastructureEnterprise Software
Liran Eshel(Founder)Zohar Kaufman(Founder)
Co-investorsBessemer Venture PartnersCisco InvestmentsKreos CapitalRed Dot Capital PartnersTitan Capital PartnersVenrock+1 more
Mush Foods produces 50CUT, a line of mushroom root (mycelium) and mushroom products designed to be mixed with ground meat or poultry to reduce emissions and add nutrition.
AgTechClimate TechFoodTechChicago, US
Ashley Thompson(Executive Officer, Director)inJoanna Dutta(Executive Officer)Guillermo Freile(Executive Officer)in
BoardSam McBride(Director)
Co-investorsLever VCSiddhi Capital
Israeli AI company whose BodyTalk platform dubs and lip-syncs video into 29 languages while preserving the speaker's voice.
Guy Piekarzin
Co-investorsGround Up VenturesPlug and Play VenturesR-Squared VenturesStorm Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Foundational
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.























